Haemonetics | HAE - Creditori Commerciali

Prezzo Delle Azioni
58.58
Cambio Giornaliero
-0.32 -0.54%
Mensile
-4.42%
Annuale
-8.47%
Q1 Previsione
56.82




Creditori Commerciali Cambiamento Data
Avanos Medical USD 55.5M 1.3M 2025-12
Baxter International USD 999M 46M 2025-12
Becton, Dickinson and Co. USD 6.14B 4.16B 2025-12
Boston Scientific USD 1.14B 142M 2025-12
Cerus USD 25.47M 5.05M 2025-09
Cooper Companies USD 225.8M 74.6M 2025-12
Fresenius EUR 1.08B 65M 2025-09
Fresenius Medical Care EUR 835.55M 109.7M 2025-12
Globus Medical USD 98.85M 11.62M 2025-12
Haemonetics USD 48.69M 13M 2025-12
Hologic USD 201.1M 573.5M 2025-12
ICU Medical USD 154.37M 17.38M 2025-12
Intuitive Surgical USD 1.92B 179.7M 2025-12
Masimo USD 103M 14.9M 2025-12
Medtronic USD 2.57B 12M 2025-12
Merit Medical Systems USD 60.55M 4.19M 2025-12
Neogen USD 63.04M 13.56M 2025-09
OraSure Technologies USD 6.52M 161K 2025-12
Plus Therapeutics 9.22M 2.07M 2025-03
Quidel USD 279.4M 65.7M 2025-12
ResMed USD 250.41M 16.37M 2025-12
STAAR Surgical USD 11.57M 2.39M 2025-12
Steris USD 285.1M 23.8M 2025-12
Stryker USD 1.5B 56M 2025-09
Surmodics USD 2.79M 400K 2024-09
Teleflex USD 130.2M 35.71M 2025-12
Terumo JPY 97.49B 4.46B 2025-12
Thermo Fisher Scientific USD 3.62B 502M 2025-12
US Physical Therapy USD 6.06M 1.36M 2025-12
Zimmer Biomet Holdings USD 303M 12.3M 2025-12